Pyxis Oncology, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:PYXS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Total assets 135.87 M123.22 M105.6 M91.52 M64.3 M54.92 M Total liabilities 32.76 M35.57 M36.83 M38.11 M33.03 M43.48 M Total equity 103.1 M87.64 M68.78 M53.41 M31.27 M11.44 M Total liabilities & shareholders' equities 135.87 M123.22 M105.6 M91.52 M64.3 M54.92 M Total debt —————— Net debt ——————

News

Pyxis Oncology appoints Thomas Civik as interim CEO

Pyxis Oncology stock price target raised to $7 by H.C. Wainwright

Analysts Sound Alarm On Pyxis Oncology's Tiny Trial - Pyxis Oncology (NASDAQ:PYXS)

Tesla To $444? Here Are 10 Top Analyst Forecasts For Friday - AGCO (NYSE:AGCO), Assurant (NYSE:AIZ)

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%

Pyxis Oncology stock falls as RBC cuts price target on complex trial data

Pyxis Oncology, Inc. (PYXS) Discusses Preliminary Phase 1 Data for MICVO in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Transcript

Pyxis Oncology, Inc. (PYXS) Discusses Preliminary Phase 1 Data for MICVO in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma - Slideshow (NASDAQ:PYXS) 2025-12-18

Pyxis Oncology stock plummets after early-stage cancer drug data

Nasdaq Gains Over 200 Points; US Inflation Slows To 2.7% - Actelis Networks (NASDAQ:ASNS), Athira Pharma (NASDAQ:ATHA)

Pyxis Oncology reports positive data for head and neck cancer drug

Dow Surges 400 Points; Accenture Earnings Top Views - Accenture (NYSE:ACN), Actelis Networks (NASDAQ:ASNS)